Surgical division - Neurosurgery / radiosurgery
Gamma Knife: for which brain conditions is stereotactic radiosurgery indicated?
Gamma Knife is an intracranial stereotactic radiosurgery platform. Despite its name, it is not a scalpel: radiation beams converge with great precision on a target in the brain or at the base of the skull. The indication depends mainly on the nature, volume and location of the lesion, age, symptoms and possible alternatives.
Written by the Polycrabat Sevamed team · Published on · Updated on
In brief
- Gamma Knife refers to a radiosurgery technique, not a disease or a single indication.
- Radiosurgery is mainly suited to well-defined intracranial targets of a size compatible with precise irradiation.
- The choice between observation, surgery, radiosurgery, fractionated radiotherapy or systemic treatment is multidisciplinary.
Gamma Knife: radiosurgery, not open surgery
The term “Gamma Knife” can be misleading: there is no blade and, in most treatments, the skull is not opened. It is a stereotactic radiosurgery platform that concentrates many radiation beams on a target inside the skull. Each individual beam delivers a limited dose to the tissues it passes through, while their convergence makes it possible to deliver a high and very precise dose to the target.
How does the treatment work?
The pathway generally involves very high-precision imaging and a stereotactic immobilisation system, depending on the platform and the indication. The target and the organs to be protected are outlined, then a dose plan is calculated. The patient is then positioned on the machine. The radiation itself is painless; it is mainly the immobilisation, the duration or anxiety that some patients may find uncomfortable.
Depending on the system, immobilisation may use a stereotactic frame attached to the skull under local anaesthetic or, for certain indications, a mask. The details should be explained by the centre before treatment.
What happens afterwards?
Many patients go home quickly or after a short period of observation, but follow-up is essential. Radiosurgery does not act like the immediate removal of a mass: a tumour may shrink slowly or simply stop growing; a vascular malformation may take months or years to close. Follow-up MRI scans are therefore scheduled.
What are the risks and limits?
The effects depend on the area treated and the dose: tiredness, headaches, temporary swelling, temporary worsening of symptoms or, more rarely, radiation necrosis. Corticosteroids may be prescribed in certain situations. A lesion that is too large, compression requiring decompression or the absence of a tissue diagnosis may make another strategy more appropriate.
Neighbouring tissues receive a lower dose than the target, but not zero. A neurosurgical emergency or a target that is too diffuse also lead to other treatments being preferred: the platform should never be chosen simply because it is available.
Questions to ask the team
- Why prefer radiosurgery to surgery or fractionated radiotherapy?
- Is the diagnosis certain enough without a biopsy?
- What is the goal: controlling growth, reducing the risk of bleeding or treating a symptom?
- What schedule of follow-up MRI scans is planned?
What Polycrabat Sevamed can coordinate
The neurosurgical file can be referred for a specialist assessment including the imaging and the treatments already received. The decision to use radiosurgery must be taken by the medical team after studying the target and the alternatives.
Frequently asked questions
Does Gamma Knife require opening the skull?
Radiosurgery does not involve open surgery on the skull. Depending on the platform, immobilisation may use a stereotactic frame or an adapted mask.
Does the treatment work immediately?
The biological effect is gradual. For a tumour, the aim is often to control growth; for some AVMs, closure takes time.
Can all brain tumours be treated this way?
No. The type, size, location and clinical context determine whether radiosurgery is appropriate.
This content provides general medical information. It does not replace a consultation or a personalised decision by your care team. In case of serious or sudden symptoms, contact the emergency services in your country or a doctor without delay.
Further reading
Pages of the website related to this guide
Related guides
Would you like a file to be reviewed?
The Polycrabat Sevamed coordination team directs your request to the doctors concerned. It does not make any diagnosis.
All Health Info guides
Care pathways and tests
- Organising your medical pathway in Morocco, from request to return
- When to ask for a second opinion? Useful cases and limits
- EVASAN to Morocco: when is it necessary?
- Medical stay in Morocco: preparing continuity of care
- Personalised check-up: which tests according to age and risk?
- CT, MRI, PET scan, ultrasound: which test to choose?
- PET scan in oncology: indications and limits
- Morocco–Africa medical cooperation: missions and skills
Preparing your care in Morocco: practical steps
- Choosing a medical facility in Morocco: the criteria
- Medical estimate for a hospital stay in Morocco
- Cost of a private hospital stay in Morocco: the items
- Visa for medical treatment in Morocco: steps and documents
- Sending your medical file to Morocco: documents and formats
- Referring doctors: referring a patient to Morocco
- Preparing for a hospital stay in Morocco: admission and packing
- Accompanying a relative in hospital in Morocco: the guide
- Flying after an operation and preparing follow-up at home
Medical evacuation and medical transport
Critical care, specialised techniques and rehabilitation
Neurology and neurosurgery
- Stroke: every minute counts, signs, diagnosis and aftercare
- Brain tumours: diagnosis and treatments
- Meningioma: monitoring, surgery or radiosurgery?
- Gamma Knife: indications for brain radiosurgery
- Hydrocephalus: signs, tests and treatments
- Herniated disc: when should you see a neurosurgeon?
- Spine surgery: when is an operation needed?
Cardiology
- High blood pressure: an often silent disease
- Heart rhythm disorders: when should a pacemaker be considered?
- Rheumatic heart disease: protecting the heart valves
- Coronary angiography, angioplasty and stents: when are they useful?
- Heart surgery: assessment, hospital stay and follow-up
- Congenital heart disease in children: signs and treatments
Oncology
- Cancer: preparing a treatment pathway in Morocco
- Cancer: why the multidisciplinary team meeting is essential
- Pathology: reviewing slides before treating cancer
- Breast and gynaecological cancers: screening and diagnosis
- Cervical cancer: from HPV screening to treatment
- Prostate cancer: PSA, MRI, biopsy and treatments
- Liver cancer: diagnosis and choosing the right treatment
- Radiotherapy, brachytherapy, chemotherapy: the differences
- Radiotherapy in Morocco: organising your treatment
Infectious diseases and haematology
- Malaria: signs, diagnosis and prompt treatment
- Typhoid fever: signs, diagnosis and treatment
- Meningitis: recognising a neurological and infectious emergency
- Tuberculosis: diagnosis, treatment and follow-up until cure
- HIV: testing, treatment and living with a controlled infection
- Hepatitis B and C: detecting the infection and protecting the liver
- Sickle cell disease: screening, crises and long-term follow-up
- Anaemia: find the cause before treating
Internal medicine, kidneys and breathing
Surgery, urology and trauma
- Minimally invasive surgery: benefits, limits and indications
- Orthopaedic surgery in Morocco: joint replacement and fractures
- Inguinal hernia: when to monitor and when to operate?
- Gallstones: when is surgery needed?
- Kidney stones: pain, tests and lithotripsy
- Benign prostatic hyperplasia: urinary symptoms
- Hand injuries: preserving function after trauma
How is it decided whether a lesion can be treated?
The decision depends on the diagnosis, the size, the number of lesions, their location, their proximity to the optic nerves or brainstem, the presence of a mass effect, symptoms, age, general health and treatments already received. The ASTRO guidelines on brain metastases support stereotactic radiosurgery for selected patients, but a large tumour causing compression may lead to open surgery being discussed.
Possible indications, depending on the case, include certain brain metastases, vestibular schwannomas, certain meningiomas, certain arteriovenous malformations and other intracranial lesions. Radiosurgery may also be discussed for certain neurological pain conditions such as trigeminal neuralgia. The words “Gamma Knife” are therefore never an indication in themselves: the diagnosis and the multidisciplinary strategy remain central.
For a vestibular schwannoma, size, hearing, compression of the brainstem and symptoms guide the choice between monitoring, radiosurgery and surgery. For an arteriovenous malformation, radiosurgery is mainly intended for small lesions or those located in areas where surgery is risky; its effect is delayed and the risk of bleeding is not removed immediately.